Clinical trial

Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)

NCT02594072

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-04-01

PhaseNA

Study timeline

Study start (unknown)2016-04-01Date precision: month

Registry last updated2023-11-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

stereotactic ablative radiotherapyRADIATION

external beam radiation therapyRADIATION

Zoladex ®DRUG

Sponsors & collaborators

University of British Columbialead sponsor

British Columbia Cancer Agencycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02594072 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.